Role of HbA1c in Predicting Adverse Pregnancy Outcomes

NCT06676254 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2024-11-06

No results posted yet for this study

Summary

This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.

Conditions

  • Gestational Diabetes

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-27
Primary Completion
2026-06-26
Completion
2026-06-26

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06676254 on ClinicalTrials.gov